# Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

> clinical trial · VERIFIED · 2026-07-10

Status: NOT_YET_RECRUITING · Sponsor: Zhujiang Hospital · Condition: Relapsed or Refractory Acute Leukemia

- Company: Zhujiang Hospital
- Sector: Relapsed or Refractory Acute Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT07696481

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.